The global Microbiome Therapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Microbiome Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbiome Therapies.

Report Scope

The Microbiome Therapies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Microbiome Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Microbiome Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Microbiome Therapies Market Report

Report Metric	Details
Report Name	Microbiome Therapies Market
CAGR	5%
Segment by Type	Bacteria Fungi Virus Others
Segment by Application	Testing Centres Research Labs Horticulture Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	uBiome, Evolve BioSystems, Indigo Agriculture, Pivot Bio, Concentric Ag, Epibiome, CosmosID, Human Longevity, Ajinomoto Cambrooke, AnimalBiome
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Microbiome Therapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Microbiome Therapies Market report?

Ans: The main players in the Microbiome Therapies Market are uBiome, Evolve BioSystems, Indigo Agriculture, Pivot Bio, Concentric Ag, Epibiome, CosmosID, Human Longevity, Ajinomoto Cambrooke, AnimalBiome

What are the Application segmentation covered in the Microbiome Therapies Market report?

Ans: The Applications covered in the Microbiome Therapies Market report are Testing Centres, Research Labs, Horticulture, Others

What are the Type segmentation covered in the Microbiome Therapies Market report?

Ans: The Types covered in the Microbiome Therapies Market report are Bacteria, Fungi, Virus, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Microbiome Therapies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Bacteria

1.2.3 Fungi

1.2.4 Virus

1.2.5 Others

1.3 Market by Application

1.3.1 Global Microbiome Therapies Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Testing Centres

1.3.3 Research Labs

1.3.4 Horticulture

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Microbiome Therapies Market Perspective (2019-2030)

2.2 Microbiome Therapies Growth Trends by Region

2.2.1 Global Microbiome Therapies Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Microbiome Therapies Historic Market Size by Region (2019-2024)

2.2.3 Microbiome Therapies Forecasted Market Size by Region (2025-2030)

2.3 Microbiome Therapies Market Dynamics

2.3.1 Microbiome Therapies Industry Trends

2.3.2 Microbiome Therapies Market Drivers

2.3.3 Microbiome Therapies Market Challenges

2.3.4 Microbiome Therapies Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Microbiome Therapies Players by Revenue

3.1.1 Global Top Microbiome Therapies Players by Revenue (2019-2024)

3.1.2 Global Microbiome Therapies Revenue Market Share by Players (2019-2024)

3.2 Global Microbiome Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Microbiome Therapies Revenue

3.4 Global Microbiome Therapies Market Concentration Ratio

3.4.1 Global Microbiome Therapies Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Microbiome Therapies Revenue in 2023

3.5 Microbiome Therapies Key Players Head office and Area Served

3.6 Key Players Microbiome Therapies Product Solution and Service

3.7 Date of Enter into Microbiome Therapies Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Microbiome Therapies Breakdown Data by Type

4.1 Global Microbiome Therapies Historic Market Size by Type (2019-2024)

4.2 Global Microbiome Therapies Forecasted Market Size by Type (2025-2030)

5 Microbiome Therapies Breakdown Data by Application

5.1 Global Microbiome Therapies Historic Market Size by Application (2019-2024)

5.2 Global Microbiome Therapies Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Microbiome Therapies Market Size (2019-2030)

6.2 North America Microbiome Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Microbiome Therapies Market Size by Country (2019-2024)

6.4 North America Microbiome Therapies Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Microbiome Therapies Market Size (2019-2030)

7.2 Europe Microbiome Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Microbiome Therapies Market Size by Country (2019-2024)

7.4 Europe Microbiome Therapies Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Microbiome Therapies Market Size (2019-2030)

8.2 Asia-Pacific Microbiome Therapies Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Microbiome Therapies Market Size by Region (2019-2024)

8.4 Asia-Pacific Microbiome Therapies Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Microbiome Therapies Market Size (2019-2030)

9.2 Latin America Microbiome Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Microbiome Therapies Market Size by Country (2019-2024)

9.4 Latin America Microbiome Therapies Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Microbiome Therapies Market Size (2019-2030)

10.2 Middle East & Africa Microbiome Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Microbiome Therapies Market Size by Country (2019-2024)

10.4 Middle East & Africa Microbiome Therapies Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 uBiome

11.1.1 uBiome Company Detail

11.1.2 uBiome Business Overview

11.1.3 uBiome Microbiome Therapies Introduction

11.1.4 uBiome Revenue in Microbiome Therapies Business (2019-2024)

11.1.5 uBiome Recent Development

11.2 Evolve BioSystems

11.2.1 Evolve BioSystems Company Detail

11.2.2 Evolve BioSystems Business Overview

11.2.3 Evolve BioSystems Microbiome Therapies Introduction

11.2.4 Evolve BioSystems Revenue in Microbiome Therapies Business (2019-2024)

11.2.5 Evolve BioSystems Recent Development

11.3 Indigo Agriculture

11.3.1 Indigo Agriculture Company Detail

11.3.2 Indigo Agriculture Business Overview

11.3.3 Indigo Agriculture Microbiome Therapies Introduction

11.3.4 Indigo Agriculture Revenue in Microbiome Therapies Business (2019-2024)

11.3.5 Indigo Agriculture Recent Development

11.4 Pivot Bio

11.4.1 Pivot Bio Company Detail

11.4.2 Pivot Bio Business Overview

11.4.3 Pivot Bio Microbiome Therapies Introduction

11.4.4 Pivot Bio Revenue in Microbiome Therapies Business (2019-2024)

11.4.5 Pivot Bio Recent Development

11.5 Concentric Ag

11.5.1 Concentric Ag Company Detail

11.5.2 Concentric Ag Business Overview

11.5.3 Concentric Ag Microbiome Therapies Introduction

11.5.4 Concentric Ag Revenue in Microbiome Therapies Business (2019-2024)

11.5.5 Concentric Ag Recent Development

11.6 Epibiome

11.6.1 Epibiome Company Detail

11.6.2 Epibiome Business Overview

11.6.3 Epibiome Microbiome Therapies Introduction

11.6.4 Epibiome Revenue in Microbiome Therapies Business (2019-2024)

11.6.5 Epibiome Recent Development

11.7 CosmosID

11.7.1 CosmosID Company Detail

11.7.2 CosmosID Business Overview

11.7.3 CosmosID Microbiome Therapies Introduction

11.7.4 CosmosID Revenue in Microbiome Therapies Business (2019-2024)

11.7.5 CosmosID Recent Development

11.8 Human Longevity

11.8.1 Human Longevity Company Detail

11.8.2 Human Longevity Business Overview

11.8.3 Human Longevity Microbiome Therapies Introduction

11.8.4 Human Longevity Revenue in Microbiome Therapies Business (2019-2024)

11.8.5 Human Longevity Recent Development

11.9 Ajinomoto Cambrooke

11.9.1 Ajinomoto Cambrooke Company Detail

11.9.2 Ajinomoto Cambrooke Business Overview

11.9.3 Ajinomoto Cambrooke Microbiome Therapies Introduction

11.9.4 Ajinomoto Cambrooke Revenue in Microbiome Therapies Business (2019-2024)

11.9.5 Ajinomoto Cambrooke Recent Development

11.10 AnimalBiome

11.10.1 AnimalBiome Company Detail

11.10.2 AnimalBiome Business Overview

11.10.3 AnimalBiome Microbiome Therapies Introduction

11.10.4 AnimalBiome Revenue in Microbiome Therapies Business (2019-2024)

11.10.5 AnimalBiome Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Microbiome Therapies Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Bacteria

Table 3. Key Players of Fungi

Table 4. Key Players of Virus

Table 5. Key Players of Others

Table 6. Global Microbiome Therapies Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Microbiome Therapies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Microbiome Therapies Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Microbiome Therapies Market Share by Region (2019-2024)

Table 10. Global Microbiome Therapies Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Microbiome Therapies Market Share by Region (2025-2030)

Table 12. Microbiome Therapies Market Trends

Table 13. Microbiome Therapies Market Drivers

Table 14. Microbiome Therapies Market Challenges

Table 15. Microbiome Therapies Market Restraints

Table 16. Global Microbiome Therapies Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Microbiome Therapies Market Share by Players (2019-2024)

Table 18. Global Top Microbiome Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Therapies as of 2023)

Table 19. Ranking of Global Top Microbiome Therapies Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Microbiome Therapies Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Microbiome Therapies Product Solution and Service

Table 23. Date of Enter into Microbiome Therapies Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Microbiome Therapies Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Microbiome Therapies Revenue Market Share by Type (2019-2024)

Table 27. Global Microbiome Therapies Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Microbiome Therapies Revenue Market Share by Type (2025-2030)

Table 29. Global Microbiome Therapies Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Microbiome Therapies Revenue Market Share by Application (2019-2024)

Table 31. Global Microbiome Therapies Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Microbiome Therapies Revenue Market Share by Application (2025-2030)

Table 33. North America Microbiome Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Microbiome Therapies Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Microbiome Therapies Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Microbiome Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Microbiome Therapies Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Microbiome Therapies Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Microbiome Therapies Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Microbiome Therapies Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Microbiome Therapies Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Microbiome Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Microbiome Therapies Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Microbiome Therapies Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Microbiome Therapies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Microbiome Therapies Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Microbiome Therapies Market Size by Country (2025-2030) & (US$ Million)

Table 48. uBiome Company Detail

Table 49. uBiome Business Overview

Table 50. uBiome Microbiome Therapies Product

Table 51. uBiome Revenue in Microbiome Therapies Business (2019-2024) & (US$ Million)

Table 52. uBiome Recent Development

Table 53. Evolve BioSystems Company Detail

Table 54. Evolve BioSystems Business Overview

Table 55. Evolve BioSystems Microbiome Therapies Product

Table 56. Evolve BioSystems Revenue in Microbiome Therapies Business (2019-2024) & (US$ Million)

Table 57. Evolve BioSystems Recent Development

Table 58. Indigo Agriculture Company Detail

Table 59. Indigo Agriculture Business Overview

Table 60. Indigo Agriculture Microbiome Therapies Product

Table 61. Indigo Agriculture Revenue in Microbiome Therapies Business (2019-2024) & (US$ Million)

Table 62. Indigo Agriculture Recent Development

Table 63. Pivot Bio Company Detail

Table 64. Pivot Bio Business Overview

Table 65. Pivot Bio Microbiome Therapies Product

Table 66. Pivot Bio Revenue in Microbiome Therapies Business (2019-2024) & (US$ Million)

Table 67. Pivot Bio Recent Development

Table 68. Concentric Ag Company Detail

Table 69. Concentric Ag Business Overview

Table 70. Concentric Ag Microbiome Therapies Product

Table 71. Concentric Ag Revenue in Microbiome Therapies Business (2019-2024) & (US$ Million)

Table 72. Concentric Ag Recent Development

Table 73. Epibiome Company Detail

Table 74. Epibiome Business Overview

Table 75. Epibiome Microbiome Therapies Product

Table 76. Epibiome Revenue in Microbiome Therapies Business (2019-2024) & (US$ Million)

Table 77. Epibiome Recent Development

Table 78. CosmosID Company Detail

Table 79. CosmosID Business Overview

Table 80. CosmosID Microbiome Therapies Product

Table 81. CosmosID Revenue in Microbiome Therapies Business (2019-2024) & (US$ Million)

Table 82. CosmosID Recent Development

Table 83. Human Longevity Company Detail

Table 84. Human Longevity Business Overview

Table 85. Human Longevity Microbiome Therapies Product

Table 86. Human Longevity Revenue in Microbiome Therapies Business (2019-2024) & (US$ Million)

Table 87. Human Longevity Recent Development

Table 88. Ajinomoto Cambrooke Company Detail

Table 89. Ajinomoto Cambrooke Business Overview

Table 90. Ajinomoto Cambrooke Microbiome Therapies Product

Table 91. Ajinomoto Cambrooke Revenue in Microbiome Therapies Business (2019-2024) & (US$ Million)

Table 92. Ajinomoto Cambrooke Recent Development

Table 93. AnimalBiome Company Detail

Table 94. AnimalBiome Business Overview

Table 95. AnimalBiome Microbiome Therapies Product

Table 96. AnimalBiome Revenue in Microbiome Therapies Business (2019-2024) & (US$ Million)

Table 97. AnimalBiome Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Microbiome Therapies Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Microbiome Therapies Market Share by Type: 2023 VS 2030

Figure 3. Bacteria Features

Figure 4. Fungi Features

Figure 5. Virus Features

Figure 6. Others Features

Figure 7. Global Microbiome Therapies Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Microbiome Therapies Market Share by Application: 2023 VS 2030

Figure 9. Testing Centres Case Studies

Figure 10. Research Labs Case Studies

Figure 11. Horticulture Case Studies

Figure 12. Others Case Studies

Figure 13. Microbiome Therapies Report Years Considered

Figure 14. Global Microbiome Therapies Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Microbiome Therapies Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Microbiome Therapies Market Share by Region: 2023 VS 2030

Figure 17. Global Microbiome Therapies Market Share by Players in 2023

Figure 18. Global Top Microbiome Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Therapies as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Microbiome Therapies Revenue in 2023

Figure 20. North America Microbiome Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Microbiome Therapies Market Share by Country (2019-2030)

Figure 22. United States Microbiome Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Microbiome Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Microbiome Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Microbiome Therapies Market Share by Country (2019-2030)

Figure 26. Germany Microbiome Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Microbiome Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Microbiome Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Microbiome Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Microbiome Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Microbiome Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Microbiome Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Microbiome Therapies Market Share by Region (2019-2030)

Figure 34. China Microbiome Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Microbiome Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Microbiome Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Microbiome Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Microbiome Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Microbiome Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Microbiome Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Microbiome Therapies Market Share by Country (2019-2030)

Figure 42. Mexico Microbiome Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Microbiome Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Microbiome Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Microbiome Therapies Market Share by Country (2019-2030)

Figure 46. Turkey Microbiome Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Microbiome Therapies Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. uBiome Revenue Growth Rate in Microbiome Therapies Business (2019-2024)

Figure 49. Evolve BioSystems Revenue Growth Rate in Microbiome Therapies Business (2019-2024)

Figure 50. Indigo Agriculture Revenue Growth Rate in Microbiome Therapies Business (2019-2024)

Figure 51. Pivot Bio Revenue Growth Rate in Microbiome Therapies Business (2019-2024)

Figure 52. Concentric Ag Revenue Growth Rate in Microbiome Therapies Business (2019-2024)

Figure 53. Epibiome Revenue Growth Rate in Microbiome Therapies Business (2019-2024)

Figure 54. CosmosID Revenue Growth Rate in Microbiome Therapies Business (2019-2024)

Figure 55. Human Longevity Revenue Growth Rate in Microbiome Therapies Business (2019-2024)

Figure 56. Ajinomoto Cambrooke Revenue Growth Rate in Microbiome Therapies Business (2019-2024)

Figure 57. AnimalBiome Revenue Growth Rate in Microbiome Therapies Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions